NASDAQ: LIFEEthos Technologies Inc Stock
$17.18+0.67 (+4.06%)
Updated Jun 11, 2026
LIFE Price
$17.18
Fair Value Price
$3.38
Market Cap
$1.08B
52 Week Low
$9.45
52 Week High
$32.50
P/E
N/A
P/B
2.45x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.4
Operating Cash Flow
N/A
Beta
1.79
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
LIFE Overview
Ethos Technologies Inc. functions as a third-party administrator for insurance policies in various global markets, including the United States, India, and Singapore. The company offers "Ethos," a comprehensive technology platform designed to transform the process of purchasing, distributing, and overseeing risk for life insurance products among consumers, agents, and insurance providers. Their product portfolio features term, whole, and indexed universal life insurance policies, complemented by offerings such as wills and estate planning assistance, and supplemental health insurance. Ethos serves a broad clientele, encompassing individual consumers, insurance agents, agencies, and carriers. Incorporated in 2016 and based in San Francisco, California, the organization was formerly known as Ethos Insurance Corporation until its name change in August 2016.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine LIFE's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Property & Casualty Insurance
Industry Rating
C
LIFE
Ranked#19 of 19
Ranked#19 of 19
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $28.60 | C | |
| $106.51 | C | |
| $91.71 | C |
Be the first to know about important LIFE news, forecast changes, insider trades & much more!
LIFE News
Overview
Due Diligence Score
–
Industry Average (36)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how LIFE scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
LIFE ($17.18) is overvalued by 407.78% relative to our estimate of its Fair Value price of $3.38 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
LIFE ($17.18) is not significantly undervalued (407.78%) relative to our estimate of its Fair Value price of $3.38 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
LIFE is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
There are 30 more LIFE due diligence checks available for Premium users.
Valuation
LIFE fair value
Fair Value of LIFE stock based on Discounted Cash Flow (DCF)
Price
$17.18
Fair Value
$3.38
Overvalued by
407.78%
LIFE ($17.18) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
LIFE ($17.18) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
LIFE price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.45x
Industry
1.54x
LIFE is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
LIFE's financial health
Profit margin
Revenue
$193.1M
Net Income
-$166.4M
Profit Margin
-89.1%
Assets to liabilities
Assets
$619.4M
Liabilities
$178.0M
Debt to equity
0.4
LIFE's short-term assets ($259.35M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
LIFE's short-term assets ($259.35M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
LIFE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$31.2M
Investing
-$52.1M
Financing
$37.8M
LIFE vs Property & Casualty Insurance Stocks
Ethos Technologies Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.